YF-ZIKprM/E vaccine protects against Zika infection and congenital malformations in mouse models Jan. 18, 2019
Pediatric phase III study of Ragwitek sublingual allergy immunotherapy meets primary endpoint Jan. 16, 2019
Valneva announces promising phase I interim data on Chikungunya vaccine candidate VLA-1553 Jan. 7, 2019
RSS